1. Adding Stereotactic Radiation to the Multidisciplinary Armamentarium for Localized Renal Cell Carcinoma: Ready for Primetime?

   • Elizabeth L. Koehne
   • Sarah P. Psutka

   ASO Perspectives 19 June 2023 Pages: 6947 - 6949

2. Rethinking Risk Modeling with Machine Learning

   • Adam Yala
   • Kevin S. Hughes

   ASO Perspectives 13 August 2023 Pages: 6950 - 6952

3. Timing is Everything: Neoadjuvant Versus Adjuvant Immunotherapy in Patients with Resectable Metastatic Melanoma

   • Ashley M. Holder
   • Jennifer A. Wargo
   • Merrick I. Ross

   ASO Perspectives 19 August 2023 Pages: 6953 - 6957

   

4. Breast Cancer Genes and Contralateral Prophylactic Mastectomy: Beyond BRCA

   • Todd M. Tuttle
   • Jane Yuet Ching Hui

   Breast Oncology 26 August 2023 Pages: 6958 - 6959

5. Resection of Papillary Thyroid Carcinoma Involving a Functioning Recurrent Laryngeal Nerve: Pushing Boundaries to Preserve Nerve Function

   • Anthony T. Saxton
   • Randall P. Scheri

   Endocrine Tumors 15 September 2023 Pages: 6960 - 6962

6. Positive Margin for Low-Grade Appendiceal Mucinous Neoplasms (LAMN): To Observe or to Reoperate?

   • Hussein M. Hariri
   • Sameer H. Patel

   Gastrointestinal Oncology 30 July 2023 Pages: 6963 - 6964

7. Affordable Care Act Medicaid Expansion Association with Improved Cancer Outcomes: Quality at What Cost?

   • Timothy L. Fitzgerald
   • Liam R. Fitzgerald

   Hepatobiliary Tumors 05 September 2023 Pages: 6965 - 6966

8. Understanding Barriers to Enrollment in Adjuvant Clinical Trials: Insights into Patient Eligibility Criteria from the Adjuvant S-1 for Cholangiocarcinoma Trial (JCOG1202, ASCOT)

   • Divya Sood
   • Skye C. Mayo

   Hepatobiliary Tumors 08 September 2023 Pages: 6967 - 6969

9. Postoperative Complications After Retroperitoneal Sarcoma Surgery: Can We Avoid Them?

   • Fabio Tirotta
   • Samuel J. Ford

   Sarcoma 03 August 2023 Pages: 6970 - 6971

10. Sowing the Seeds of Evasion: Lung Adenocarcinoma Plans Its Escape

    • Jonathan Villena-Vargas

    Thoracic Oncology 09 August 2023 Pages: 6972 - 6973

11. Editorial Comment on “Changes in Sarcopenia Status Predict Survival Among Patients with Resectable Esophageal Cancer”

    • Connor J. Wakefield

    Thoracic Oncology 23 August 2023 Pages: 6974 - 6975

12. Exploring the Relationship: Low-Grade Appendiceal Mucinous Neoplasms (LAMN) and Mucinous Adenocarcinoma as Phases of the Same Disease Spectrum

    • Lance D. Miller
    • Konstantinos I. Votanopoulos

    Translational Research 28 August 2023 Pages: 6976 - 6977

13. Current Insurance Policy Coverage for Screening Mammography in Transgender and Gender-Diverse Individuals

    • Chandler S. Cortina
    • Emily L. Siegel
    • Melinda Stolley

    ASO Research Letter 24 August 2023 Pages: 6978 - 6980

    

14. Decreasing Environmental Operating Room Chemotherapy Levels Following Heated Intraperitoneal Chemotherapy (HIPEC) Through Implementation of Standard Protocols

    • Neal Bhutiani
    • Michael G. White
    • Richard E. Royal

    ASO Research Letter 25 August 2023 Pages: 6981 - 6982

15. Design and Implementation of a Learner-Centered Self-Paced Peritoneal Oncology Education Program

    • Varun V. Bansal
    • Hunter D. D. Witmer
    • Kiran K. Turaga

    ASO Research Letter 26 August 2023 Pages: 6983 - 6986

    

16. Evaluating Geographic Health Disparities in Cancer Care: Example of the Modifiable Areal Unit Problem

    • Constance P. Fontanet
    • Heather Carlos
    • Andrew P. Loehrer

    ASO Research Letter 01 September 2023 Pages: 6987 - 6989

    

17. Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease

    • Jennifer Q. Zhang
    • Carlos Henrique Dos Anjos
    • Mary L. Gemignani

    Breast Oncology 03 September 2023 Pages: 6990 - 6999

    

18. Great Debate: The Surgeon’s Role in Locoregional Management of Stage IV Breast Cancer

    • Anthony Lucci
    • Leah S. Kim
    • Tari A. King

    Breast Oncology 19 August 2023 Pages: 7000 - 7007

19. Insufficient Reporting of Race and Ethnicity in Breast Cancer Clinical Trials

    • Grace Keegan
    • Angelena Crown
    • Kathie-Ann Joseph

    Breast Oncology 01 September 2023 Pages: 7008 - 7014

    

20. Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection

    • Shruti Zaveri
    • Shlermine Everidge
    • Henry M. Kuerer

    Breast Oncology 17 July 2023 Pages: 7015 - 7025

    

21. Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer

    • Kai Huang
    • James Jakub
    • Sarah McLaughlin

    Breast Oncology 25 July 2023 Pages: 7026 - 7035

    

22. The Use of Wearable Activity Monitors to Measure Upper Limb Physical Activity After Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy

    • Nur Amalina Che Bakri
    • Richard M. Kwasnicki
    • Daniel R. Leff

    Breast Oncology Open access 28 July 2023 Pages: 7036 - 7045

    

23. Enhanced Surgical Decision-Making Tools in Breast Cancer: Predicting 2-Year Postoperative Physical, Sexual, and Psychosocial Well-Being following Mastectomy and Breast Reconstruction (INSPiRED 004)

    • Cai Xu
    • André Pfob
    • Chris Sidey-Gibbons

    Breast Oncology Open access 30 July 2023 Pages: 7046 - 7059

    

24. Distinct Prognosis of Minimal Residual Disease According to Breast Cancer Subtype in Patients with Breast or Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy

    • Jieon Go
    • Jee Hyun Ahn
    • Seho Park

    Breast Oncology 03 August 2023 Pages: 7060 - 7068

    

25. Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ

    • Claudia J. C. Meurs
    • Sara van Bekkum
    • Pieter J. Westenend

    Breast Oncology Open access 04 August 2023 Pages: 7069 - 7080

    

26. Surgeon and Radiologist Evaluation of Electromagnetic Chip Localization for Benign and Malignant Breast Lesions

    • Nicholas T. Champion
    • Blaise Mooney
    • Marie Catherine Lee

    Breast Oncology 08 August 2023 Pages: 7081 - 7090

    

27. Long-Term Patient-Reported Outcomes Comparing Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery: A Propensity Score-Matched Analysis

    • Linda M. Pak
    • Regina Matar-Ujvary
    • Mary L. Gemignani

    Breast Oncology 09 August 2023 Pages: 7091 - 7098

    

28. Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment

    • Kirithiga Ramalingam
    • Elle Clelland
    • Rita A. Mukhtar

    Breast Oncology Open access 10 August 2023 Pages: 7099 - 7106

    

29. Analysis of Specimen Mammography with Artificial Intelligence to Predict Margin Status

    • Kevin A. Chen
    • Kathryn E. Kirchoff
    • Shawn M. Gomez

    Breast Oncology 10 August 2023 Pages: 7107 - 7115

    

30. Satisfaction and Well-Being After Contralateral Prophylactic Mastectomy Among BRCA Mutation Carriers and Noncarriers: A Longitudinal Analysis of BREAST-Q Domains

    • Sara P. Myers
    • Audree B. Tadros
    • Minna K. Lee

    Breast Oncology 15 August 2023 Pages: 7116 - 7123

    

31. Routine Use of a Standardized Mastectomy Diagram by Surgeons Improves Accuracy and Timeliness of the Final Pathological Report

    • Andrew Seto
    • Alexandra Pass
    • Helen A. Pass

    Breast Oncology Open access 19 August 2023 Pages: 7124 - 7130

    

32. ASO Author Reflections: The Importance of a Multidisciplinary Approach to Axillary Management in the Upfront Mastectomy Patient

    • Shruti Zaveri
    • Henry M. Kuerer

    ASO Author Reflections 03 August 2023 Pages: 7131 - 7132

33. ASO Author Reflections: Objective Outcome Measure of Upper Limb Function Following Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy

    • Nur Amalina Che Bakri
    • Richard M. Kwasnicki
    • Daniel R. Leff

    ASO Author Reflections Open access 23 July 2023 Pages: 7133 - 7134

34. ASO Author Reflections: Enhancing Surgical Decision-Making for Breast Reconstruction—Machine Learning-Driven Prediction of Postoperative Quality of Life

    • Cai Xu
    • André Pfob
    • Chris Sidey-Gibbons

    ASO Author Reflections Open access 30 July 2023 Pages: 7135 - 7136

35. ASO Author Reflections: Menopausal Status Does Not Predict Successful Breast Conservation Surgery After Neoadjuvant Chemotherapy in Invasive Lobular Carcinoma

    • Kirithiga Ramalingam
    • Rita Mukhtar

    ASO Author Reflections 10 August 2023 Pages: 7137 - 7138

36. ASO Author Reflections: Standardized Mastectomy Diagrams Improve the Accuracy and Timeliness of Pathology Reports

    • Andrew Seto
    • Alexandra Pass
    • Helen A. Pass

    ASO Author Reflections 06 September 2023 Pages: 7139 - 7140

37. ASO Visual Abstract: Extremely Low Incidence of Local–Regional Recurrences Observed among T1–2N1 (one or two Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy without Completion Axillary Node Dissection

    • Shruti Zaveri
    • Shlermine Everidge
    • Henry M. Kuerer

    ASO Visual Abstract 23 August 2023 Pages: 7141 - 7142

38. ASO Visual Abstract: Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node-Negative T1 Triple-Negative Breast Cancer

    • Kai Huang
    • James Jakub
    • Sarah McLaughlin

    ASO Visual Abstract 14 August 2023 Pages: 7143 - 7143

39. ASO Visual Abstract: The Use of Wearable Activity Monitors to Measure the Upper Limb Physical Activity After Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy

    • Nur Amalina Che Bakri
    • Richard M. Kwasnicki
    • Daniel R. Leff

    ASO Visual Abstract 19 August 2023 Pages: 7144 - 7145

40. ASO Visual Abstract: Enhanced Surgical Decision-Making Tools in Breast Cancer—Predicting 2-Year Postoperative Physical, Sexual, and Psychosocial Well-Being Following Mastectomy and Breast Reconstruction (INSPiRED 004)

    • Cai Xu
    • André Pfob
    • Chris Sidey-Gibbons

    ASO Visual Abstract 19 August 2023 Pages: 7146 - 7147

41. ASO Visual Abstract: Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis of Ductal Carcinoma In Situ

    • Claudia J. C. Meurs
    • Sara van Bekkum
    • Pieter J. Westenend

    ASO Visual Abstract 11 August 2023 Pages: 7148 - 7149

42. ASO Visual Abstract: Long-Term Patient-Reported Outcomes Comparing Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery—A Propensity Score-Matched Analysis

    • Linda M. Pak
    • Regina Matar-Ujvary
    • Mary L. Gemignani

    ASO Visual Abstract 08 September 2023 Pages: 7150 - 7151

43. ASO Visual Abstract: Successful Breast Conservation After Neoadjuvant Chemotherapy in Lobular Breast Cancer: The Role of Menopausal Status in Response to Treatment

    • Kirithiga Ramalingam
    • Elle Clelland
    • Rita A. Mukhtar

    ASO Visual Abstract 25 August 2023 Pages: 7152 - 7152

44. ASO Visual Abstract: Analysis of Specimen Mammography with Artificial Intelligence to Predict Margin Status

    • Kevin A. Chen
    • Kathryn E. Kirchoff
    • Shawn M. Gomez

    ASO Visual Abstract 29 August 2023 Pages: 7153 - 7153

45. ASO Visual Abstract: Satisfaction and Well-Being After Contralateral Prophylactic Mastectomy Among BRCA Mutation Carriers and Noncarriers—A Longitudinal Analysis of BREAST-Q Domains

    • Sara P. Myers
    • Audree B. Tadros
    • Minna K. Lee

    ASO Visual Abstract 01 September 2023 Pages: 7154 - 7154

46. Nipple-Sparing Mastectomy for Early Breast Cancer: Less is More?

    • Francisco Pimentel Cavalcante
    • Felipe Pereira Zerwes
    • Guilherme Novita Garcia

    Breast Oncology 30 August 2023 Pages: 7155 - 7156

47. Shaving Papillary Thyroid Carcinoma Involving Functioning Recurrent Laryngeal Nerve: Safety of Incomplete Tumor Resection and Nerve Sparing

    • Hyoung Shin Lee
    • Yeongjoon Kim
    • Kang Dae Lee

    Endocrine Tumors 21 August 2023 Pages: 7157 - 7164

    

48. Improved Adherence to ATA Medullary Thyroid Cancer Treatment Guidelines

    • Jessica Liu McMullin
    • Jyotirmay Sharma
    • Neil D. Saunders

    Endocrine Tumors 11 November 2022 Pages: 7165 - 7171

    

49. The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study

    • Jia-ying Chen
    • Nai-si Huang
    • Qing-hai Ji

    Endocrine Tumors 05 August 2023 Pages: 7172 - 7180

    

50. ASO Author Reflections: Is it Safe to Shave Papillary Thyroid Carcinoma Involving a Functioning Recurrent Laryngeal Nerve with Incomplete Tumor Resection?

    • Hyoung Shin Lee
    • Yeongjoon Kim
    • Kang Dae Lee

    ASO Author Reflections 16 August 2023 Pages: 7181 - 7182